Evaxion A/S
EVAX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001828253
No open-market purchases or sales by Evaxion A/S insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.93M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Evaxion A/S changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 6 | 6 | 0 |
| Shares | 381.0K | 453.3K | +72.3K (+19.0%) |
| Value | $1.22M | $1.31M | +$94.2K (+7.7%) |
New holders (2)
Institutions that held Evaxion A/S at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Invst, LLC | 54,000 | $155.5K | 0.02% |
| South State Corp. | 4 | $12 | 0.00% |
Sold out (2)
Institutions that held Evaxion A/S at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Citadel Advisors LLC | 8,141 | $26.1K |
| Tower Research Capital LLC (TRC) | 30 | $96 |